Therapeutic use of cannabis in the US

Abstract

NPs are likely to encounter patients using cannabis with therapeutic intent, with or without legal authorization. During the clinical history and assessment process, NPs need to engage in frank discussion about cannabis therapeutics, including the risks and benefi ts, evidence for use, dosing considerations, potential drug interactions, and harm reduction.

Early postoperative cognitive decline—are there any preventive strategies for surgical patients in the emergency setting?

“…These findings corroborate with a diminished pro-inflammatory cytokines level in the hippocampus and prefrontal cortex several days after surgery [63]. At the present there are no human data on the consequences of cannabinoids on postoperative cognitive impairments, although this may stand for a future study subject as cannabinoids agents are suggested as treatment for a variety of neuropsychiatric disorders including depression, epilepsy, multiple sclerosis, Parkinson's disease, Alzheimer's disease [64,65].…”